HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innovation Awards In Brief

This article was originally published in The Rose Sheet

Executive Summary

CEW Beauty Awards: Cosmetic Executive Women recognized the year's most innovative products at May 1 event in New York. Best anti-aging face products in prestige and mass markets are Clinique's Even Better Skin Tone Corrector, which "virtually undoes the visible evidence of sun damage, dark patches, skin stress, age spots and even the darkening that follows acne scarring," and Procter & Gamble/Olay's Regenerist 14-Day Skin Intervention, respectively. Olay Regenerist Micro-Sculpting Cream took the prize last year for mass anti-aging. In the Bath & Body category, Avon's Anew Clinical Professional Stretch Mark Smoother, featuring firm's TriLaser technology, and The Estee Lauder Companies/Ojon's Tawaka "The Ball" take home honors for mass and prestige body treatments of the year. P&G and ELC again come out on top for their facial moisturizers - Olay Definity Color Recapture and Estee Lauder Time Zone Line and Wrinkle Reducing Moisturizer SPF 15, which contains the brand's Tri-Hyaluronic Acid Complex (1"The Rose Sheet" Oct. 27, 2008, p. 10). Zirh Holdings' Drenched face cream within the Zirh Platinum range is named best men's grooming product. Mass women's scent of 2009 is Avon's Bond Girl 007, while "G" from Coty and Gwen Stefani's Harajuku Lovers set stands out among prestige scents. CEW board members vote on winners after finalists are selected from a pool of entrants by CEW members and industry insiders
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS016172

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel